As scientists get away from very specific assays for very specific targets, novel solutions are changing the paradigm.

To keep your cells “in character,” give them the right motivation (reprogramming), direction (transfection payload), and staging (culture conditions).

Live cell-based assays (L-CBAs) have recently been developed that were designed to identify the antibodies associated with MG.

The implementation of cell-based assays can improve the process of drug discovery and development by providing important biological information about drug action mechanisms, off-target effects ...

Based on the results of these assays, the team determined that two reported inhibitors did not engage NLRP3 or functionally inhibit the target pathway.

Special focus will be given to immune effector function assays to characterize the potency and specificity of CAR-T and natural killer cells. Additionally, scalable screening methods based on recent ...

The cell-based assays market is poised for substantial growth, with an anticipated growth rate of 8-10% from 2024 to 2029. This growth trajectory is driven by a convergence of factors, including ...

Study: A cell-based, spike protein binding assay highlights differences in antibody neutralising capacity for SARS-CoV-2 variants. Image Credit: Design_Cells / Shutterstock *Important notice ...

The global cell-based assays market is set to grow from USD 17.84 billion in 2025 to USD 27.55 billion by 2030, marking a CAGR of 9.1%. This surge is fueled by the rising demand in drug discovery ...

Nexcelom Bioscience, experts in automated cell counting and analysis, will host the Modern Cell-Based Assays Virtual Symposium, November 10, 2020, at 8:00 am EST. This virtual, online symposium serves ...

Cell death assays fall into two major groups: assays that measure bona fide cell death and tests that quantify biochemical processes that are viewed as surrogate viability markers.